Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.
Clinical trial NCT07568782 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07568782
- Sponsor
- University Hospital, Lille
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-15
- Primary completion
- 2027-12-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.